[Cardiorenal syndrome, current understanding].

Area of Science:

• Cardiorenal Medicine
• Nephrology
• Cardiology

Context:

• The term cardiorenal syndrome (CRS) lacks a universally accepted definition, leading to varied interpretations.
• Interactions between the heart and kidneys are complex and bidirectional.
• Existing classifications struggle to encompass the full spectrum of CRS manifestations.

Purpose:

• To establish a clear, comprehensive classification system for cardiorenal syndrome.
• To delineate the five distinct subtypes of CRS based on primary pathology, time course, and organ involvement.
• To emphasize the bi-directional nature of heart-kidney interactions in CRS.

Summary:

• Cardiorenal syndrome (CRS) is defined as a pathophysiologic disorder involving the heart and kidneys, where dysfunction in one organ can induce dysfunction in the other.
• Five subtypes of CRS are proposed: Type I (acute heart dysfunction causing acute kidney injury), Type II (chronic heart dysfunction causing chronic kidney disease), Type III (acute kidney dysfunction causing acute heart disorder), Type IV (chronic kidney disease causing cardiac dysfunction), and Type V (systemic disease causing both cardiac and renal dysfunction).
• Biomarkers play a vital role in characterizing CRS subtypes and guiding treatment strategies.

Impact:

• Provides a standardized framework for understanding and diagnosing cardiorenal syndrome.
• Facilitates targeted therapeutic interventions for specific CRS subtypes.
• Enhances clinical management by clarifying the complex interplay between cardiac and renal health.